Loading...
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
BCR-ABL-mediated leukemias, either Chronic Myeloid Leukemia (CML) or Philadelphia positive Acute Lymphoblastic Leukemia (ALL), are the paradigm of targeted molecular therapy of cancer due to the impressive clinical responses obtained with BCR-ABL specific tyrosine kinase inhibitors (TKIs). However,...
Na minha lista:
| Udgivet i: | Adv Hematol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710905/ https://ncbi.nlm.nih.gov/pubmed/26843864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/612567 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|